Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Surgery Partners (SGRY) PT Lowered to $17 at RBC Capital
March 14, 2019 6:29 AM EDTRBC Capital analyst Frank Morgan lowered the price target on Surgery Partners (NASDAQ: SGRY) to $17.00 (from $20.00) while maintaining a Outperform rating.
... MoreSurgery Partners, Inc. (SGRY) Reports Q4 Revenues Beat Estimates
March 13, 2019 7:03 AM EDTSurgery Partners, Inc. (NASDAQ: SGRY) reported Q4 EPS of ($1.39), versus ($0.24) reported last year. Revenue for the quarter came in at $491.2 million versus the consensus estimate of $482.71 million.
Wayne DeVeydt, Chief Executive Officer of Surgery Partners, stated, Our fourth quarter results were highlighted by strong Adjusted EBITDA growth, as well as our second... More
